The Health Brief

0.0 (0)
NEWS
UPDATED WEEKLY

Welcome to EURACTIV's health Brief, your weekly update on health policy in the EU from EURACTIV's health news team: Gerardo Fortuna, Giedre Peseckyte and Clara Bauer.

26/07/2023

Understanding vaccine hesitancy in Europe

This week EURACTIV's health reporter Marta Iraola talks to Dr. Emilie Karafillakis about vaccine confidence in Europe and what is behind people's lack of trust in vaccination and public health campaigns. In this episode, the health team reunites before the summer to say goodbye to this podcast as from September health topics will be covered under Beyond the Byline podcast.

12 min
19/07/2023

AI: at the Interface of computer science and Medicine

From YouTube-recommended videos to facial recognition used to unlock smartphones, AI is already being used on a daily basis. The healthcare sector is not an exception as its ability to process vast amounts of medical data helps in diagnostics and medical image analysis. To better understand where AI is already used and what potential it holds, EURACTIV’s Giedrė Peseckytė is talking with Jakob Kather, a medical doctor and a Professor of Clinical artificial intelligence at the computer science and the medical faculty in Dresden. As he says, he is in a “quite unique position at the interface of computer science and medicine,” where with his team he is using artificial intelligence for medical decision-making and developing tomorrow's AI tools for medicine.

33 min
12/07/2023

European Health Data Space on the Parliament's Plate

As the European Parliament debates how European health data space should be shaped, EURACTIV talks with the co-rapporteur of the file, Croatian MEP Tomislav Sokol (EPP), touching on primary and secondary use of data, the reasons why parliament supports the opt-out option and what is left to discuss before the discussions can start with the Council.

26 min
05/07/2023

Balancing patients' privacy and health data's potential

European Health Data Space (EHDS) focuses on the primary and secondary use of data. While the primary use of data is data used by citizens and healthcare professionals at the national and EU levels the secondary data is to be used by researchers, policy makers and pharma. The Commission's proposal does not include any say for patients regarding the secondary use of data, while Parliament, which is currently dealing with the proposal, is vowing for an opt-out option. In the meantime, there is a petition circling calling for the empowerment of patients regarding the secondary use of their health records. About what concerns are being seen for the patients when it comes to reuse of the health data EURACTIV's Giedre Peseckyte is talking with Jan Penfrat, the senior policy advisor at the European digital rights association.

20 min
28/06/2023

The challenge of guaranteeing access to healthcare to all Ukrainian refugees

On the occasion of the first Healthcare Forum, which took place in Wąsowo, Poland last week, Euractiv spoke with the Regional Director of WHO/Europe, Dr Hans Kluge. In this interview, Dr. Kluge looked back on his meeting with the Polish and Ukrainian Ministers of Health about the Healthy Reconstruction of Ukraine. He dug into the physical and mental health needs of the refugees, but also into the limited access to sexual and reproductive rights for Ukrainian women in Poland, as some of them could not have an abortion due to the Polish law.

19 min
21/06/2023

A closer look at Europe's fertility challenge

This week EURACTIV'S health team explores why fertility is decreasing across the globe, what challenges people face when they want children and the situation of fertility treatments in Europe. For that, Health Reporter Marta Iraola talks with Dr Carlos Calhaz-Jorge, a specialist in obstetrics and gynaecology and chair of the European Society for Human Reproduction and Embryology (ESHRE).

11 min
14/06/2023

Endocrine Disrupting Chemicals: a silent threat for children's development

This week, EURACTIV’s health team dives into how endocrine-disrupting chemicals (EDC) can affect children, especially in their most important developmental years. They talk with Doctor Anders Juul, a paediatric endocrinologist at Rigshospitalet in Copenhagen. He explains how children are exposed to these chemicals and the health issues this can cause them, both as kids and as adults.

14 min
07/06/2023

Much more than a ‘party drug’

Psilocybin, MDMA or LSD might associate with party drugs but their therapeutic value is being discovered worldwide. Ian Roullier took part in two clinical trials that looked at the effects of psilocybin on depression. Through his personal experience, Roullier shares his insights on psychedelic-assisted therapy, its potential value to patients and what is needed to boost research in this field.

36 min

See All (22)

Welcome to EURACTIV's health Brief, your weekly update on health policy in the EU from EURACTIV's health news team: Gerardo Fortuna, Giedre Peseckyte and Clara Bauer.